ACCUSOL 35 POTASSIUM 4 mmol/l, solution pour hémofiltration, hémodialyse et hémodiafiltration

solution et solution pour hémofiltration pour hémodialyse et pour hémodiafiltration · hémodialyse / hémofiltration

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution et solution pour hémofiltration pour hémodialyse et pour hémodiafiltration

Routehémodialyse / hémofiltration

Ingredient entries6

CountryFrance

Product identity

At a glance

Authorisation holder: NIKKISO BELGIUM (BELGIQUE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 61278936

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for ACCUSOL 35 POTASSIUM 4 mmol/l, solution pour hémofiltration, hémodialyse et hémodiafiltration
Ingredient	Strength / reference	Source role
CHLORURE DE POTASSIUMsolution A	0,398 g1000 ml	SAGroup 4
CALCIUM (CHLORURE DE) DIHYDRATÉsolution A	0,343 g1000 ml	SAGroup 1
CHLORURE DE SODIUMsolution A	7,50 g1000 ml	SAGroup 3
CHLORURE DE MAGNÉSIUM HEXAHYDRATÉsolution A	0,136 g1000 ml	SAGroup 2
GLUCOSE MONOHYDRATÉsolution A	1,47 g1000 ml	SAGroup 5
BICARBONATE DE SODIUMsolution B	13,4 g1000 ml	SAGroup 8

Pack references

Presentations (1)

2 poche(s) (CLEARFLEX) bicompartimenté(e)(s)/à 2 compartiments polypropylène polyamide SEBS : styrène-éthylène-butylène-styrène polyéthylène suremballée(s)/surpochée(s) de 5000 ml

CIP13 3400937477390

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 61278936 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →